ReviewGenes & diseases2026
The ubiquitin system in heart and vessel pathobiology: From mechanisms to therapeutic strategies.
Review in Genes & diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiovascular disease is currently a major global challenge, and its causes are complex, encompassing genetic, lifestyle, environmental, and other factors. Ubiquitination, an important post-translational protein modification, is closely associated with cardiovascular disease and is involved in the regulation of protein degradation, signaling, and gene expression. An increasing number of studies have shown that ubiquitination plays a key regulatory role in the development and progression of cardiovascular disease. Recent research has elucidated the crucial role of ubiquitination modifications in governing various cellular processes, signaling pathways, and protein homeostasis within cardiovascular contexts. Specifically, these modifications have been implicated in cardiomyocyte injury and hypertrophy, macrophage inflammation, phenotypic changes in smooth muscle cells, and activation of fibroblasts. This review summarizes the role of ubiquitination modifications in recent years, focusing on the recognition of different substrate proteins by E3 ubiquitin ligases. These ligases are involved in the regulation of various cardiovascular disorders, such as atherosclerosis, myocardial ischemia/reperfusion injury, cardiac remodeling, cardiac arrhythmia, and hypertension. The findings provide new insights into the prevention and treatment of cardiovascular disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.